Oral multiple-dose oral form in tablet form processes for preparing it for inhibition of gastric acid secretion in mammals and man and for the treatment of gastrointestinal inflammatory diseases in mammals and man and the packaging of cross-cutting pressure ampoules

摘要

A new pharmaceutical multiple unit tableted dosage form containing as active substance an acid labile H+K+-ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.